{
    "thread": {
        "uuid": "f04813ea1513f2479f7fdf6f81e693082481564d",
        "url": "https://www.morningstar.com/news/dow-jones/2024121911250/health-care-down-on-backlash-fears-health-care-roundup",
        "site_full": "www.morningstar.com",
        "site": "morningstar.com",
        "site_section": "https://www.morningstar.com",
        "site_categories": [
            "investing",
            "financial_news",
            "finance"
        ],
        "section_title": "Morningstar | Empowering Investor Success",
        "title": "Health Care Down on Backlash Fears — Health Care Roundup | Morningstar",
        "title_full": "Health Care Down on Backlash Fears — Health Care Roundup | Morningstar",
        "published": "2024-12-20T01:24:00.000+02:00",
        "replies_count": 0,
        "participants_count": 0,
        "site_type": "news",
        "country": "US",
        "main_image": "https://images.contentstack.io/v3/assets/blt4eb669caa7dc65b2/blta7dd42ebdd7b93b8/61899b34a3c7df383578294c/morningstar-og.png",
        "performance_score": 0,
        "domain_rank": 1858,
        "domain_rank_updated": "2024-12-16T23:00:00.000+02:00",
        "social": {
            "facebook": {
                "likes": 0,
                "comments": 0,
                "shares": 0
            },
            "vk": {
                "shares": 0
            }
        }
    },
    "uuid": "f04813ea1513f2479f7fdf6f81e693082481564d",
    "url": "https://www.morningstar.com/news/dow-jones/2024121911250/health-care-down-on-backlash-fears-health-care-roundup",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": null,
    "published": "2024-12-20T01:24:00.000+02:00",
    "title": "Health Care Down on Backlash Fears — Health Care Roundup | Morningstar",
    "text": "Health Care Down on Backlash Fears — Health Care Roundup\nHealth-care companies fell amid ongoing concerns about a backlash against the industry.\nThe SPDR Select Sector Health Care exchange-traded fund, which tracks the health-care industry group of the S&P 500, turned negative for the year, giving back substantial gains.\nRoche shares slipped after the Swiss drug giant said a Parkinson's disease experimental drug missed its primary goal in a mid-stage trial, the second setback this week for candidate treatments for the neurodegenerative condition.\nThe Food and Drug Administration said a longstanding shortage of Eli Lilly's weight-loss drug Zepbound and its Type 2 diabetes medicine Mounjaro is officially over.\nVertex shares fell after it reported mixed trial results for a treatment for lumbosacral radiculopathy, a neurological disorder that causes back and leg pain.\nWrite to Rob Curran at rob.curran@dowjones.com\n(END) Dow Jones Newswires\nDecember 19, 2024 18:24 ET (23:24 GMT)\nCopyright (c) 2024 Dow Jones & Company, Inc.\nMore in Markets\nDespite the positive outlook for stocks, don’t count on another year of near-30% returns.\nFidelity’s Jurrien Timmer on Why the Stock Market Rally Has Legs in 2025\nThe Fed signaled fewer rate cuts and potentially sticky inflation in 2025.\nStocks Tumble on New Fed Rate Forecast—Here’s Why\nFed officials may be looking toward “policies” that could boost inflation.\nFed Sets Stage For Fewer (or Possibly No) Rate Cuts in 2025\nMore in Stocks\nThese undervalued utilities offer appealing dividend yields and the opportunity for growth.\nThe Best Utilities Stocks to Buy\nAdvanced Micro Devices and Caterpillar are among the stocks that fell into undervalued territory.\n14 New 4-Star Stocks\nThese stock picks stand to benefit most from developing artificial intelligence technologies as we move into 2025.",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "negative",
    "categories": [
        "Health"
    ],
    "topics": [
        "Health->health organisation",
        "Health->health care approach",
        "Health->public health"
    ],
    "ai_allow": true,
    "has_canonical": false,
    "webz_reporter": false,
    "external_links": [],
    "external_images": [],
    "entities": {
        "persons": [
            {
                "name": "Rob Curran",
                "sentiment": "none"
            }
        ],
        "organizations": [
            {
                "name": "Food and Drug Administration",
                "sentiment": "none"
            },
            {
                "name": "Eli Lilly",
                "sentiment": "none"
            },
            {
                "name": "Vertex",
                "sentiment": "none"
            },
            {
                "name": "Roche",
                "sentiment": "none"
            },
            {
                "name": "S&P",
                "sentiment": "none"
            }
        ],
        "locations": []
    },
    "syndication": {
        "syndicated": false,
        "syndicate_id": null,
        "first_syndicated": false
    },
    "rating": null,
    "crawled": "2024-12-20T01:44:19.394+02:00",
    "updated": "2024-12-20T01:44:19.394+02:00"
}